Co-Diagnostics Stock (NASDAQ: CODX) stock price, news, charts, stock research, profile.
Open | $1.140 |
Close | $1.150 |
Volume / Avg. | 18.403K / 58.992K |
Day Range | 1.140 - 1.170 |
52 Wk Range | 0.975 - 1.890 |
Market Cap | $35.323M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 1.63% |
Days to Cover | 8.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Co-Diagnostics (NASDAQ: CODX) through any online brokerage.
Other companies in Co-Diagnostics’s space includes: Precision Optics Corp (NASDAQ:POCI), LENSAR (NASDAQ:LNSR), Lucid Diagnostics (NASDAQ:LUCD), NeuroOne Medical Tech (NASDAQ:NMTC) and Femasys (NASDAQ:FEMY).
The latest price target for Co-Diagnostics (NASDAQ: CODX) was reported by HC Wainwright & Co. on Friday, March 15, 2024. The analyst firm set a price target for 2.50 expecting CODX to rise to within 12 months (a possible 121.24% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Co-Diagnostics (NASDAQ: CODX) is $1.13 last updated April 18, 2024 at 5:51 PM EDT.
There are no upcoming dividends for Co-Diagnostics.
Co-Diagnostics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Co-Diagnostics.
Co-Diagnostics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.